Bruce J. Seeley

EVP, Commerical, Seagen.

Companies

CTI BioPharmaChief operating officer Oct 3, 2017 to Mar 11, 2022¹
CTI BioPharmaEVP, Chief Commercial Officer Jul 29, 2015 to Mar 6, 2017²
NanoString TechnologiesSVP & GM, Diagnostics Jun 25, 2013 to Feb 4, 2014³
SeagenEVP, Commerical Oct 21, 2009 to Aug 24, 2011⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CTI BioPharma43,905 shares⁵Dec 31, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 31, 2021Granted 3,241 shares at $2.11 of CTI BioPharma⁵
Jun 30, 2021Granted 3,164 shares at $2.13 of CTI BioPharma⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCTI BioPharma, Chief operating officer
2
SEC EDGARCTI BioPharma, EVP, Chief Commercial Officer
3
SEC EDGARNanoString Technologies, SVP & GM, Diagnostics
4
SEC EDGARSeagen, EVP, Commerical
5
SEC EDGARCTI BioPharma shares after the filing of Dec 31, 2021